Recently it was shown that targeting MDA5 and RIG-I could effectively induce apoptotic signaling and counteract cancer cell heterogeneity in glioblastoma [13], suggesting that MDA5 and RIG-I might also be implicated in the suppression of another neurogenic cancer. The gene discussed is RIGI; the disease is cancer.